Christopher J. Layton

815 total citations
31 papers, 597 citations indexed

About

Christopher J. Layton is a scholar working on Ophthalmology, Molecular Biology and Genetics. According to data from OpenAlex, Christopher J. Layton has authored 31 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Ophthalmology, 17 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Christopher J. Layton's work include Retinal Development and Disorders (13 papers), Retinal Diseases and Treatments (12 papers) and Virus-based gene therapy research (6 papers). Christopher J. Layton is often cited by papers focused on Retinal Development and Disorders (13 papers), Retinal Diseases and Treatments (12 papers) and Virus-based gene therapy research (6 papers). Christopher J. Layton collaborates with scholars based in Australia, United Kingdom and Brazil. Christopher J. Layton's co-authors include Jason C. Steel, Neville N. Osborne, Bijay Dhungel, Glyn Chidlow, John P. M. Wood, Madeleine Adams, Robert J. Casson, José Melena, Angus Turner and Anthony J. Bron and has published in prestigious journals such as Journal of Neurochemistry, Investigative Ophthalmology & Visual Science and Oncotarget.

In The Last Decade

Christopher J. Layton

31 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher J. Layton Australia 14 352 328 124 75 59 31 597
Takahisa Koga Japan 16 356 1.0× 301 0.9× 161 1.3× 35 0.5× 52 0.9× 24 651
La‐ongsri Atchaneeyasakul Thailand 13 269 0.8× 255 0.8× 151 1.2× 73 1.0× 37 0.6× 46 541
Maria M Campos United States 15 293 0.8× 409 1.2× 107 0.9× 67 0.9× 75 1.3× 33 639
Carol A. Rasmussen United States 19 594 1.7× 484 1.5× 275 2.2× 59 0.8× 81 1.4× 50 951
Tatsuo Itakura United States 12 178 0.5× 203 0.6× 104 0.8× 33 0.4× 41 0.7× 21 463
Graziana Esposito Italy 13 345 1.0× 242 0.7× 213 1.7× 41 0.5× 39 0.7× 35 619
Fabiana D’Esposito Italy 10 179 0.5× 277 0.8× 98 0.8× 68 0.9× 31 0.5× 62 451
Dan Yi Wang Hong Kong 15 689 2.0× 432 1.3× 255 2.1× 110 1.5× 25 0.4× 16 923
George Kitsos Greece 16 443 1.3× 211 0.6× 249 2.0× 121 1.6× 13 0.2× 53 737
Edward Averbukh Israel 17 486 1.4× 382 1.2× 244 2.0× 125 1.7× 56 0.9× 42 771

Countries citing papers authored by Christopher J. Layton

Since Specialization
Citations

This map shows the geographic impact of Christopher J. Layton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Layton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Layton more than expected).

Fields of papers citing papers by Christopher J. Layton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Layton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Layton. The network helps show where Christopher J. Layton may publish in the future.

Co-authorship network of co-authors of Christopher J. Layton

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Layton. A scholar is included among the top collaborators of Christopher J. Layton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Layton. Christopher J. Layton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steel, Jason C., et al.. (2024). AAV-mediated gene therapies for glaucoma and uveitis: are we there yet?. Expert Reviews in Molecular Medicine. 26. e9–e9. 6 indexed citations
2.
3.
Li, Ye, Robert G. Smith, Jason C. Steel, & Christopher J. Layton. (2022). Attitudes of eye health practitioners towards diagnostic tests and therapies for dry eye disease in Australasia. Contact Lens and Anterior Eye. 45(6). 101724–101724. 4 indexed citations
4.
Dhungel, Bijay, et al.. (2021). The Impact of Ultraviolet Radiation on the Aetiology and Development of Uveal Melanoma. Cancers. 13(7). 1700–1700. 17 indexed citations
5.
Moyle, Peter M., et al.. (2020). Neutralisation of adeno-associated virus transduction by human vitreous humour. Gene Therapy. 28(5). 242–255. 6 indexed citations
6.
Steel, Jason C., et al.. (2020). Presence and prevalence of UV related genetic mutations in uveal melanoma: similarities with cutaneous melanoma. Neoplasma. 67(5). 958–971. 13 indexed citations
7.
Steel, Jason C., et al.. (2019). Characterisation and validation of the 8-fold quadrant dissected human retinal explant culture model for pre-clinical toxicology investigation. Toxicology in Vitro. 63. 104716–104716. 6 indexed citations
8.
Steel, Jason C., et al.. (2018). Systematic Assessment of Clinical Methods to Diagnose and Monitor Diabetic Retinal Neuropathy. Journal of Ophthalmology. 2018. 1–9. 5 indexed citations
9.
Dhungel, Bijay, et al.. (2018). Evaluation of the Glypican 3 promoter for transcriptional targeting of hepatocellular carcinoma. Gene Therapy. 25(2). 115–128. 14 indexed citations
10.
Dhungel, Bijay, et al.. (2018). MicroRNA199a-Based Post-transcriptional Detargeting of Gene Vectors for Hepatocellular Carcinoma. Molecular Therapy — Nucleic Acids. 13. 78–88. 7 indexed citations
11.
Dhungel, Bijay, et al.. (2018). miRNA122a regulation of gene therapy vectors targeting hepatocellular cancer stem cells. Oncotarget. 9(34). 23577–23588. 7 indexed citations
12.
Dhungel, Bijay, Aparna Jayachandran, Christopher J. Layton, & Jason C. Steel. (2017). Seek and destroy: targeted adeno-associated viruses for gene delivery to hepatocellular carcinoma. Drug Delivery. 24(1). 289–299. 21 indexed citations
13.
Adams, Madeleine, et al.. (2017). A Novel ABCA4 Mutation Associated with a Late-Onset Stargardt Disease Phenotype: A Hypomorphic Allele. Case Reports in Ophthalmology. 8(1). 180–184. 65 indexed citations
14.
15.
Layton, Christopher J., et al.. (2015). Familial Disorders of the Optic Disc: Presentation of a Mother and Daughter and Review of the Literature. Case Reports in Ophthalmology. 6(2). 251–259. 1 indexed citations
16.
Layton, Christopher J., et al.. (2015). Prognostic implications of imaging in atrophic macular degeneration and its use in clinical practice and clinical trial design. Clinical and Experimental Ophthalmology. 44(5). 410–421. 4 indexed citations
17.
Layton, Christopher J., Rukhsana Safa, & Neville N. Osborne. (2007). Oscillatory potentials and the b-Wave: Partial masking and interdependence in dark adaptation and diabetes in the rat. Graefe s Archive for Clinical and Experimental Ophthalmology. 245(9). 1335–1345. 28 indexed citations
18.
Turner, Angus, Christopher J. Layton, & Anthony J. Bron. (2005). Survey of eye practitioners’ attitudes towards diagnostic tests and therapies for dry eye disease. Clinical and Experimental Ophthalmology. 33(4). 351–355. 34 indexed citations
19.
Osborne, Neville N., Glyn Chidlow, Christopher J. Layton, et al.. (2004). Optic nerve and neuroprotection strategies. Eye. 18(11). 1075–1084. 81 indexed citations
20.
Layton, Christopher J., John P. M. Wood, Glyn Chidlow, & Neville N. Osborne. (2004). Neuronal death in primary retinal cultures is related to nitric oxide production, and is inhibited by erythropoietin in a glucose‐sensitive manner. Journal of Neurochemistry. 92(3). 487–493. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takahisa Koga Breakdown of academic impact, for papers by La‐ongsri Atchaneeyasakul Breakdown of academic impact, for papers by Maria M Campos Breakdown of academic impact, for papers by Carol A. Rasmussen Breakdown of academic impact, for papers by Tatsuo Itakura Breakdown of academic impact, for papers by Graziana Esposito Breakdown of academic impact, for papers by Fabiana D’Esposito Breakdown of academic impact, for papers by Dan Yi Wang Breakdown of academic impact, for papers by George Kitsos Breakdown of academic impact, for papers by Edward Averbukh
Rankless by CCL
2026